C-MER Medical Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Dennis Lam
Chief executive officer
HK$6.0m
Total compensation
| CEO salary percentage | 95.7% |
| CEO tenure | no data |
| CEO ownership | 0.9% |
| Management average tenure | no data |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For C-MER Medical Holdings (HKG:3309)
Nov 13
Is C-MER Medical Holdings (HKG:3309) A Risky Investment?
Oct 18Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%
Sep 04Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being
May 21C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point
Apr 29C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk
Feb 02C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively
Jan 17A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)
Apr 24Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal
Dec 04Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?
Sep 22Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year
Dec 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | HK$63m |
| Mar 31 2024 | n/a | n/a | HK$63m |
| Dec 31 2023 | HK$6m | HK$6m | HK$62m |
| Sep 30 2023 | n/a | n/a | HK$28m |
| Jun 30 2023 | n/a | n/a | -HK$7m |
| Mar 31 2023 | n/a | n/a | -HK$14m |
| Dec 31 2022 | HK$6m | HK$6m | -HK$22m |
| Sep 30 2022 | n/a | n/a | HK$545k |
| Jun 30 2022 | n/a | n/a | HK$23m |
| Mar 31 2022 | n/a | n/a | HK$22m |
| Dec 31 2021 | HK$6m | HK$6m | HK$22m |
| Sep 30 2021 | n/a | n/a | HK$25m |
| Jun 30 2021 | n/a | n/a | HK$28m |
| Mar 31 2021 | n/a | n/a | HK$11m |
| Dec 31 2020 | HK$4m | HK$4m | -HK$6m |
| Sep 30 2020 | n/a | n/a | -HK$10m |
| Jun 30 2020 | n/a | n/a | -HK$13m |
| Mar 31 2020 | n/a | n/a | HK$14m |
| Dec 31 2019 | HK$1m | HK$1m | HK$41m |
| Sep 30 2019 | n/a | n/a | HK$53m |
| Jun 30 2019 | n/a | n/a | HK$64m |
| Mar 31 2019 | n/a | n/a | HK$53m |
| Dec 31 2018 | HK$1m | HK$1m | HK$43m |
| Sep 30 2018 | n/a | n/a | HK$35m |
| Jun 30 2018 | n/a | n/a | HK$27m |
| Mar 31 2018 | n/a | n/a | HK$31m |
| Dec 31 2017 | HK$4m | HK$3m | HK$40m |
Compensation vs Market: Dennis's total compensation ($USD775.27K) is above average for companies of similar size in the Hong Kong market ($USD393.51K).
Compensation vs Earnings: Dennis's compensation has been consistent with company performance over the past year.
CEO
Dennis Lam (64 yo)
no data
Tenure
HK$6,018,000
Compensation
Dr. Shun Chiu Lam, JP, also known as Dennis, serves as Chairman and Chief Executive Officer of C-MER Medical Holdings Limited (formerly known as C-MER Eye Care Holdings Limited). Dr. Lam is also a director...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | no data | HK$6.02m | 0.95% HK$ 23.3m | |
| Executive Director | 7.5yrs | HK$3.81m | no data | |
| Head of Hong Kong Operation & Executive Director | 7.5yrs | HK$240.00k | 1.08% HK$ 26.5m | |
| Independent Non-Executive Director | 7yrs | HK$240.00k | no data | |
| Independent Vice Chairman of the Board | 4.1yrs | HK$759.00k | 0.025% HK$ 603.0k | |
| Independent Non-Executive Director | 1.4yrs | HK$120.00k | no data | |
| Independent Non-Executive Director | 4.1yrs | HK$240.00k | no data |
5.5yrs
Average Tenure
64yo
Average Age
Experienced Board: 3309's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 09:40 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
C-MER Medical Holdings Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fangqi Dai | China Merchants Securities (HK) Co., Ltd |
| Wei Zheng | Tianfeng Securities Brokerage Co., Ltd |